rs149000560

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 1P and 20B. PP3BP4_StrongBP6_Very_StrongBS1BS2

The NM_031471.6(FERMT3):​c.130G>A​(p.Gly44Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00766 in 1,613,364 control chromosomes in the GnomAD database, including 86 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0057 ( 6 hom., cov: 33)
Exomes 𝑓: 0.0079 ( 80 hom. )

Consequence

FERMT3
NM_031471.6 missense

Scores

9
5
4

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 9.32

Publications

16 publications found
Variant links:
Genes affected
FERMT3 (HGNC:23151): (FERM domain containing kindlin 3) Kindlins are a small family of proteins that mediate protein-protein interactions involved in integrin activation and thereby have a role in cell adhesion, migration, differentiation, and proliferation. The protein encoded by this gene has a key role in the regulation of hemostasis and thrombosis. This protein may also help maintain the membrane skeleton of erythrocytes. Mutations in this gene cause the autosomal recessive leukocyte adhesion deficiency syndrome-III (LAD-III). Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jan 2010]
FERMT3 Gene-Disease associations (from GenCC):
  • leukocyte adhesion deficiency 3
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

PP3
Multiple lines of computational evidence support a deleterious effect 10: AlphaMissense, BayesDel_noAF, Cadd, Dann, Eigen, FATHMM_MKL, phyloP100way_vertebrate, PROVEAN, REVEL, REVEL [when max_spliceai, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.011366427).
BP6
Variant 11-64207494-G-A is Benign according to our data. Variant chr11-64207494-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 195388.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00566 (862/152236) while in subpopulation NFE AF = 0.00832 (566/68012). AF 95% confidence interval is 0.00775. There are 6 homozygotes in GnomAd4. There are 397 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FERMT3NM_031471.6 linkc.130G>A p.Gly44Arg missense_variant Exon 2 of 15 ENST00000345728.10 NP_113659.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FERMT3ENST00000345728.10 linkc.130G>A p.Gly44Arg missense_variant Exon 2 of 15 1 NM_031471.6 ENSP00000339950.5

Frequencies

GnomAD3 genomes
AF:
0.00567
AC:
863
AN:
152118
Hom.:
6
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00142
Gnomad AMI
AF:
0.0252
Gnomad AMR
AF:
0.00543
Gnomad ASJ
AF:
0.0268
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.000471
Gnomad MID
AF:
0.0538
Gnomad NFE
AF:
0.00832
Gnomad OTH
AF:
0.00718
GnomAD2 exomes
AF:
0.00600
AC:
1501
AN:
250244
AF XY:
0.00607
show subpopulations
Gnomad AFR exome
AF:
0.00167
Gnomad AMR exome
AF:
0.00385
Gnomad ASJ exome
AF:
0.0272
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00144
Gnomad NFE exome
AF:
0.00807
Gnomad OTH exome
AF:
0.00967
GnomAD4 exome
AF:
0.00787
AC:
11493
AN:
1461128
Hom.:
80
Cov.:
31
AF XY:
0.00773
AC XY:
5619
AN XY:
726852
show subpopulations
African (AFR)
AF:
0.00173
AC:
58
AN:
33476
American (AMR)
AF:
0.00392
AC:
175
AN:
44688
Ashkenazi Jewish (ASJ)
AF:
0.0287
AC:
749
AN:
26070
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39688
South Asian (SAS)
AF:
0.00183
AC:
158
AN:
86186
European-Finnish (FIN)
AF:
0.00188
AC:
100
AN:
53308
Middle Eastern (MID)
AF:
0.0458
AC:
263
AN:
5744
European-Non Finnish (NFE)
AF:
0.00853
AC:
9480
AN:
1111596
Other (OTH)
AF:
0.00845
AC:
510
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
676
1351
2027
2702
3378
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
368
736
1104
1472
1840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00566
AC:
862
AN:
152236
Hom.:
6
Cov.:
33
AF XY:
0.00533
AC XY:
397
AN XY:
74422
show subpopulations
African (AFR)
AF:
0.00142
AC:
59
AN:
41548
American (AMR)
AF:
0.00543
AC:
83
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.0268
AC:
93
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5164
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4826
European-Finnish (FIN)
AF:
0.000471
AC:
5
AN:
10606
Middle Eastern (MID)
AF:
0.0544
AC:
16
AN:
294
European-Non Finnish (NFE)
AF:
0.00832
AC:
566
AN:
68012
Other (OTH)
AF:
0.00710
AC:
15
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
45
90
135
180
225
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00828
Hom.:
25
Bravo
AF:
0.00625
TwinsUK
AF:
0.00809
AC:
30
ALSPAC
AF:
0.00727
AC:
28
ESP6500AA
AF:
0.00204
AC:
9
ESP6500EA
AF:
0.00966
AC:
83
ExAC
AF:
0.00568
AC:
689
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.00943
EpiControl
AF:
0.00795

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
May 28, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Leukocyte adhesion deficiency 3 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Jun 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

FERMT3: BS1, BS2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.89
BayesDel_addAF
Uncertain
0.014
T
BayesDel_noAF
Pathogenic
0.26
CADD
Pathogenic
27
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.14
T;D;.
Eigen
Pathogenic
0.83
Eigen_PC
Pathogenic
0.77
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
0.98
D;D;D
MetaRNN
Benign
0.011
T;T;T
MetaSVM
Benign
-0.30
T
MutationAssessor
Uncertain
2.5
.;M;M
PhyloP100
9.3
PrimateAI
Uncertain
0.71
T
PROVEAN
Pathogenic
-6.1
D;D;D
REVEL
Pathogenic
0.70
Sift
Uncertain
0.0010
D;D;D
Sift4G
Uncertain
0.0040
D;D;D
Polyphen
1.0, 1.0
.;D;D
Vest4
0.87, 0.89
MutPred
0.90
Gain of MoRF binding (P = 0.0028);Gain of MoRF binding (P = 0.0028);Gain of MoRF binding (P = 0.0028);
MVP
0.79
MPC
1.3
ClinPred
0.019
T
GERP RS
4.5
PromoterAI
-0.0037
Neutral
Varity_R
0.87
gMVP
0.79
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs149000560; hg19: chr11-63974966; COSMIC: COSV99043647; COSMIC: COSV99043647; API